AbstractIntroductionDelayed-onset heparin-induced thrombocytopenia (HIT) is a rare side effect of heparin. This prothrombotic condition can present its first signs up to three weeks following heparin administration even if heparin use has been stopped.ReportA 54-year-old claudicant patient underwent a suprageniculate limb bypass with heparin administration. Despite bypass patency, our patient developed recurrent wound necrosis and kept complaining of ischemic pain. The patient then developed toe necrosis and underwent leg amputation.ConclusionDelayed-onset HIT is a rare condition that should be looked for and promptly managed in patients with peripheral vasculopathy following heparin administration
Background: Low molecular weight heparins (LMWHs) are currently used as a standard for anti-thrombot...
Abstract Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is ...
Heparin use, both prophylactically and therapeutically, is prevalent among hospitalized patients. Pa...
AbstractIntroductionDelayed-onset heparin-induced thrombocytopenia (HIT) is a rare side effect of he...
An extremely rare case with delayed-onset heparin-induced thrombocytopenia (HIT) is described. A 46-...
Heparin-induced thrombocytopenia (HIT) is an immune-mediated thrombocytopenia resulting from prior h...
AbstractHeparin-induced thrombocytopenia is a rare but serious complication of heparin therapy. Most...
A 44-year-old woman with deep vein thrombosis caused by intrapelvic peritonitis associated with aden...
Copyright © 2015 Yoshitsugu Nakamura et al. This is an open access article distributed under the Cre...
Lower extremity peripheral arterial disease is primarily caused by atherosclerosis and thromboemboli...
BACKGROUND: Unfractionated and low-molecular-weight heparin are commonly used in the prevention and ...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90371/1/j.1875-9114.1996.tb02981.x.pd
Background. Heparin-induced thrombocytopenia (HIT) is a transient, antibody-mediated thrombocytopeni...
Vascular thrombosis is a common clinical feature of both essential thrombocythemia (ET) and heparin-...
Heparin- induced thrombocytopenia (HIT) is an antibody mediated adverse effect of heparin therapy wh...
Background: Low molecular weight heparins (LMWHs) are currently used as a standard for anti-thrombot...
Abstract Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is ...
Heparin use, both prophylactically and therapeutically, is prevalent among hospitalized patients. Pa...
AbstractIntroductionDelayed-onset heparin-induced thrombocytopenia (HIT) is a rare side effect of he...
An extremely rare case with delayed-onset heparin-induced thrombocytopenia (HIT) is described. A 46-...
Heparin-induced thrombocytopenia (HIT) is an immune-mediated thrombocytopenia resulting from prior h...
AbstractHeparin-induced thrombocytopenia is a rare but serious complication of heparin therapy. Most...
A 44-year-old woman with deep vein thrombosis caused by intrapelvic peritonitis associated with aden...
Copyright © 2015 Yoshitsugu Nakamura et al. This is an open access article distributed under the Cre...
Lower extremity peripheral arterial disease is primarily caused by atherosclerosis and thromboemboli...
BACKGROUND: Unfractionated and low-molecular-weight heparin are commonly used in the prevention and ...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90371/1/j.1875-9114.1996.tb02981.x.pd
Background. Heparin-induced thrombocytopenia (HIT) is a transient, antibody-mediated thrombocytopeni...
Vascular thrombosis is a common clinical feature of both essential thrombocythemia (ET) and heparin-...
Heparin- induced thrombocytopenia (HIT) is an antibody mediated adverse effect of heparin therapy wh...
Background: Low molecular weight heparins (LMWHs) are currently used as a standard for anti-thrombot...
Abstract Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is ...
Heparin use, both prophylactically and therapeutically, is prevalent among hospitalized patients. Pa...